Robust Q3 Outcomes Drive Guardant’s Inventory 15% Larger In 20 Days

HomeInvesting

Robust Q3 Outcomes Drive Guardant’s Inventory 15% Larger In 20 Days

Guardant Well being (GH) presents non-invasive most cancers analysis assessments and relies out of


Guardant Well being (GH) presents non-invasive most cancers analysis assessments and relies out of the us The corporate has seen its inventory rally 15% since its Q3 outcomes had been introduced.  The corporate reported robust leads to Q3 with gross sales development coming in at $61 Mil – a 181% soar year-on-year. Earnings loss for the corporate additionally narrowed to -$0.14 per share – a lot better than the consensus estimate of -$0.37. Moreover, the corporate raised its income steering for full-year 2019 to the $202-$207 Mil vary from $180-$190 Mil.

We step again from these current swings to overview Guardant Health’s efficiency over the previous couple of years, as a context for what would possibly come subsequent. Our Interactive dashboard – Why has Guardant Health rallied by 15% in the last 20 days?, opinions the close to time period causes and the large image.

 

The context for the previous couple of years:

A more in-depth look At Guardant Well being’s Whole Revenues over the previous couple of years and the outlook.



nasdaq.com